# Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction

> **NCT07362446** · PHASE2 · RECRUITING · sponsor: **Nyrada Pty Ltd** · enrollment: 300 (estimated)

## Conditions studied

- Myocardial Infarction
- Reperfusion Injury
- AMI
- STEMI (ST Elevation MI)

## Interventions

- **DRUG:** Xolatryp
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07362446
- **Lead sponsor:** Nyrada Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-22
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07362446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07362446, "Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction". Retrieved via AI Analytics 2026-07-23 from https://api.ai-analytics.org/clinical/NCT07362446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*